SU‐GG‐T‐150: Commissioning and Validation of a Novel Measurement‐Based IMRT QA Method, Incorporating Dose Recalculation On Patient CT Data

Abstract

Purpose: A novel measurement‐based IMRT QA method was tested which provides an accurate reconstruction of the 3D dose distribution in the patient model. This approach is a significant improvement over current QA methods since it allows direct and independent comparison of the doses calculated by the treatment planning system (TPS), including the 3D spatial dose distribution overlaid on CT data and contoured structures, as well as DVHs. Method and Materials: The challenging RPC Head and Neck phantom was used for initial evaluation. A 6 MV, 7 field, 79 segment, step and shoot plan was developed satisfying required dose metrics. A 2D‐array of dose chambers (MatriXX, IBA Dosimetry) was mounted on a linear accelerator. This device captured the delivered IMRT plan fluence in a pretreatment QA context. The measurement data were read directly by the control software (COMPASS, IBA Dosimetry), which also provides the ability to import patient plan data from the TPS. The COMPASS software also includes a dose calculation engine and head fluence model. Beam commissioning procedures analogous to those of a TPS were required. Reconstructed dose and DVHs were compared to those calculated by the TPS. Results: The beam model in the COMPASS software was able to predict percentage depth dose and X and Y profiles (Dmax, 5, 10, 20 cm depths) for MLC‐defined apertures ranging from 1×1–20×20 cm∧2 to within 1.5% (percentage depth‐dose), 2.0% (in‐field profiles), and 2.5% (out‐of‐field profiles). The reconstructed doses in the RPC Head & Neck phantom were within −3 to +4% of those in the treatment planning system. DVHs compared to within 1%. Conclusion: A novel measurement‐based IMRT QA method was tested. Reconstructed doses were overlaid on CT data and contoured structures, to enable a clinically relevant understanding of delivered under‐ or over‐doseages as compared to the TPS plan. Research partially sponsored by IBA Dosimetry.

Biological X-ray irradiator characterization for use with small animals and cells

“…Studies using small animals and cell experiments have become indispensable for cancer research before clinical implementation of a new therapy (1,2). They assist with the understanding of ionizing radiation interactions with tissues and cells, which is crucial for translational research of new effective radiotherapy techniques.…”

“…Other factors such as no facility-licensing requirements, and less rigorous and easier maintenance also add to the advantages of an X-ray unit (2,8). …”

The Octavius1500 2D ion chamber array and its associated phantoms: Dosimetric characterization of a new prototype

“…As rotational treatments are taking up an ever increasing share of all radiotherapy treatments, the most commonly used verification methods have gradually moved from field-byfield to composite plan verification. Composite plan measurement systems produce either planar (2D) [7][8][9][10][11][12][13] or three dimensional (3D) [14][15][16][17][18][19][20][21][22][23] dose information. Planar data are obtained from the measurement in a straightforward manner, with data manipulation mostly limited to the application of energy (and sometimes angle) dependent calibration files and correction factors.…”

A new transmission methodology for quality assurance in radiotherapy based on radiochromic film measurements

“…(12) Poppe et al (13) described and evaluated a technique using an ionization chamber matrix coupled to the linac treatment head in order to conduct a pretreatment QA, as well as for therapeutic applications. McCurdy and colleagues (14) tested MatriXX (IBA Dosimetry, Schwarzenbruck, Germany), a bidimensional array of ionization chambers coupled to the linac treatment head for performing IMRT QA. All of these studies are examples of transmission QA methodologies; they present the main advantage of coupling the measurement device to the linac treatment head, making the beam always perpendicular to the device's sensitive volume, eliminating variations in its response as a function of the gantry's angular displacement.…”